MAPT and Alzheimer disease: Collectively, these combined behavioural, histological and molecular data indicate the bioavailability and strong capacity of Kaem and Rhap to retard memory loss, while simultaneously decreasing both Aβ and Tau pathologies in the 3xTg AD mouse model.